Finance 22 May 2026

Heritage Financial Stock Is Quiet Now, but One Bank Margin Test Could Decide What Comes Next

Heritage Financial Stock Is Quiet Now, but One Bank Margin Test Could Decide What Comes Next

Heritage Financial Corp. shares closed at $27.25 Friday, down 0.33%, lagging bank sector gains as investors weighed the impact of its Olympic Bancorp acquisition. First-quarter net income was $18.9 million, with net interest margin rising to 3.96%. Management expects cost savings after completing systems integration in Q3. A recent SEC filing disclosed a cybersecurity incident involving an internal file-share server.
May 30, 2026
GTEC Trades Higher Even as $1 Rule Stays in Focus

GTEC Trades Higher Even as $1 Rule Stays in Focus

Greenland Technologies shares rose 2.5% to $0.58 Friday, still well below Nasdaq’s $1 minimum bid requirement. The company has until Sept. 8 to regain compliance or risk delisting. Q1 revenue climbed to $25.54 million and net income to $5.75 million, but EPS fell as share count increased. Most sales come from transmission products for Chinese forklift makers; its U.S. electric vehicle unit remains mostly suspended.
May 22, 2026
Locafy Ticks Up as AI Search Stock Approaches June Event

Locafy Ticks Up as AI Search Stock Approaches June Event

Locafy Limited shares traded near $4.01 Friday on Nasdaq, up 0.5% in light volume, with a market cap of about $7.21 million. The company plans to launch its Poseidon Answer Engine Optimization platform in June, aiming to boost AI-driven search visibility. Trading volume was below 1,000 shares late morning, highlighting the stock’s volatility risk. Competitors include Yext and Semrush in the AI search space.
May 22, 2026
KNDI Shares Stay Below $1 as Nasdaq Deadline Looms

KNDI Shares Stay Below $1 as Nasdaq Deadline Looms

Kandi Technologies shares traded at 72 cents Friday morning in New York, remaining below Nasdaq’s $1 minimum bid requirement. The company has until Nov. 2 to regain compliance or risk delisting. Kandi reported 2025 net revenue of $87.4 million, down sharply from 2024, with most sales from off-road vehicles. Broader U.S. markets rose ahead of Memorial Day, but Kandi’s stock lagged.
May 22, 2026
1RT Acquisition Holds at $10.22 with Crypto-SPAC Deadline Near

1RT Acquisition Holds at $10.22 with Crypto-SPAC Deadline Near

1RT Acquisition Corp.’s Class A shares traded at $10.22 Friday, about six cents below their $10.28 redemption value, with a market cap near $220 million and low volume. The SPAC reported $177.4 million in trust and “substantial doubt” about its ability to continue as a going concern. Investors await a merger target in digital assets, while competing crypto IPOs draw attention. Markets will close Monday for Memorial Day.
May 22, 2026
GridAI Drops After Debt Agreement as Traders Watch Warrants

GridAI Drops After Debt Agreement as Traders Watch Warrants

GridAI Technologies shares dropped 7.8% to $4.25 late Friday morning after the company settled a loan default with $800,000 in cash and 71,482 shares. GridAI recently raised $7.79 million through private placements and reported 2025 revenue of $36,251 with a net loss of $6.55 million. The company warned of “substantial doubt” about its ability to continue as a going concern.
May 22, 2026
Larimar Shares Fall, FDA Submission Seen as Next Hurdle

Larimar Shares Fall, FDA Submission Seen as Next Hurdle

Larimar Therapeutics shares fell 3.36% to $3.45 Friday as investors awaited a planned June start to its rolling FDA application for nomlabofusp, a protein-replacement drug for Friedreich’s ataxia. The company ended March with $200.4 million in cash and projected funding into Q2 2027. Shareholders approved raising authorized common shares to 215 million. The FDA has approved only one other FA treatment to date.
May 22, 2026
LiveOne Stock Jumps Again as Traders Chase the Cash Story Before Memorial Day

LiveOne Stock Jumps Again as Traders Chase the Cash Story Before Memorial Day

LiveOne shares rose 4.5% to $6.753 on Friday, extending a weekly gain near 28% amid heavy trading and recent company updates. The Nasdaq-listed audio firm reported $5.5 million in new PodcastOne cash, revised fiscal 2027 targets, and restructuring at its Custom Personalization Solutions unit. Market value stood near $91 million. U.S. markets will close Monday for Memorial Day.
May 22, 2026
IGAC Stock Barely Moves as This Tiny SPAC Tests Investors’ Patience Near $10

IGAC Stock Barely Moves as This Tiny SPAC Tests Investors’ Patience Near $10

Invest Green Acquisition Corp. shares traded near $9.97–$9.99 Friday with almost no volume, below the March 31 redemption value of $10.12. The Nasdaq-listed SPAC has not named a merger target and reported $174.6 million in trust assets in its latest filing. Market feeds from Robinhood, Kraken, and Investing.com showed little price movement. The company raised $172.5 million in its November 2025 IPO.
May 22, 2026
Cass Stock Slips Before Dividend Date as Freight Data Teases a Recovery

Cass Stock Slips Before Dividend Date as Freight Data Teases a Recovery

Cass Information Systems shares fell 0.57% to $46.24 in light early trading Friday, with volume at 2,990 shares, well below average. The company declared a 32-cent quarterly dividend, payable June 15 to holders as of June 5. Cass’s April Transportation Index showed shipments down 4.4% year-on-year but up slightly from March. First-quarter net revenue rose 5.8% to $49.1 million; net income slipped 1.5% to $8.8 million.
May 22, 2026
Baker Hughes’ $13.6 Billion Chart Deal Gets EU Timing Shift—Why BKR Shares Moved

Baker Hughes’ $13.6 Billion Chart Deal Gets EU Timing Shift—Why BKR Shares Moved

Baker Hughes shares fell 0.59% to $65.41 in early New York trading Friday after EU regulators set a June 26 deadline for reviewing its $13.6 billion takeover of Chart Industries. The broader U.S. indexes were higher at the time. The European Commission could clear the deal or launch a deeper probe. Baker Hughes aims to expand in LNG and industrial technology with the acquisition.
May 22, 2026
Xenetic Biosciences Shares Edge Down Ahead of ASCO Update

Xenetic Biosciences Shares Edge Down Ahead of ASCO Update

Xenetic Biosciences shares slipped 4 cents to $2.90 in thin early Nasdaq trading Friday, with only 144 shares changing hands. The company holds $7.3 million in cash and is set to present cancer drug research at an ASCO poster session on June 1. Xenetic is still considering strategic alternatives. First-quarter royalty revenue rose 36% to $807,000, while net loss narrowed to $456,000.
May 22, 2026
AvePoint Stock Climbs Before the Bell as Wall Street Tests Its AI Governance Bet

AvePoint Stock Climbs Before the Bell as Wall Street Tests Its AI Governance Bet

AvePoint shares rose 2.44% to $10.49 in premarket trading Friday after reporting first-quarter revenue of $117.2 million, up 26% year over year. SaaS revenue climbed 35% to $93.4 million and annual recurring revenue reached $435.2 million. Goldman Sachs and Scotiabank both lowered their price targets after earnings. The stock remains well below its 52-week high of $19.95.
May 22, 2026
BullFrog AI Stock Slips Before the Bell as Nasdaq’s $1 Clock Keeps Ticking

BullFrog AI Stock Slips Before the Bell as Nasdaq’s $1 Clock Keeps Ticking

BullFrog AI Holdings shares fell 1.97% to $0.6519 in premarket trading Friday, after closing at $0.6650 Thursday. The stock remains below Nasdaq’s $1 minimum bid requirement, with an Aug. 10 deadline to regain compliance. BullFrog last reported no revenue and a $1.59 million net loss for the first quarter. No new company press releases have been issued since April 22.
May 22, 2026
1 19 20 21 22 23 212

Stock Market Today

  • How to Value National Australia Bank (NAB) Shares Using P/E Ratio
    May 29, 2026, 10:18 PM EDT. National Australia Bank Ltd (ASX: NAB) trades around $37, attracting yield-focused investors. A key valuation tool is the price-earnings (P/E) ratio, which compares share price to yearly earnings per share. NAB's P/E ratio stands at 16.5x based on a $37.33 share price and $2.26 earnings per share (EPS). This is below the banking sector average of 18x. Applying the sector average P/E to NAB's EPS suggests a fair value of about $40.72, hinting NAB shares might be undervalued compared to peers. The P/E ratio provides a useful benchmark but should be combined with other analysis methods for robust investment decisions.